A recent quantitative electrochemiluminiscence assay (ECLIA) [12] measured 7.9–11.9 in PBMC from five controls and 1.1–4.8 pg/μg frataxin in 11 FRDA patients (reduction to 27% of controls), and showed no overlap between the two groups. The gene discussed is FXN; the disease is Friedreich ataxia.